Tech Stock Selloff: What Canadians Need to Know

The TSX outperformed Shopify (TSX:SHOP)(NYSE:SHOP) stock last week. Here’s why it happened, and what investors should do about it.

| More on:
Watch for the Warning Signs Stock Market Prices Trends 3d Illustration

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

A tech stock pullback was always an inevitability. But what wasn’t so obvious was the effect that a vaccine breakthrough might have on tech stocks. However, after last week’s Moderna (NASDAQ:MRNA) hopes buoyed markets both sides of the border, it’s clear that tech has an allergy to vaccines. Let’s explore some of the themes of last week’s market movements.

Tech stocks sank on vaccine hopes

Shopify (TSX:SHOP)(NYSE:SHOP) was down 10% over the preceding five days of trading. Early suggestions for the dip pinned the blame on investors suddenly getting spooked by Shopify’s high valuation. Such pundits overlook the nature of tech stocks. The whole point of these high-momentum plays is that bulls run them as far as they can. Bold latecomers leap on and ride the upside, and so it continues.

So, what changed? Why did Shopify suddenly tank? The most likely explanation is that biopharma outfit Moderna published a potential vaccine breakthrough. Tech stocks clearly don’t like vaccine breakthroughs. This is because the pandemic, and the resultant quarantine culture, supports their growth. It might seem obvious, in retrospect, that digitalization thrives on social isolation.

So, while Moderna leapt, Shopify sank. Other names sank with it. Docebo was down 4%, and Kinaxis flopped by 8.7%. There were wider losses, too. Twitter suffered a humiliating privacy breach on Thursday, with its verified users unable to Tweet after a Bitcoin scam targeted 130 top users. The hack cost Twitter stock 4% after hours. Shopify’s woes accumulated Friday when the platform went down.

Kinaxis’s supply chain software business was boosted by the pandemic’s emphasis on the precision management of essential goods distribution. Docebo’s cloud-based training model likewise benefited from a stay-at-home world. It barely needs to be pointed out that Shopify thrives on the online shopping trend and digitalization of retail. So, of course these names are allergic to a vaccine.

The quarantine boost was a one-off

But let’s get back to Shopify. This stock was never going to revisit the initial boost it got from the lockdown. As customers migrated en masse to online shopping, Shopify saw a massive uptick. Fast forward to last week, and the announcement of a potential vaccine breakthrough brought tech investors down to Earth with a bump.

And it just got worse on Friday. According to the Shopify Support account on Twitter: “Some merchants are currently unable to access their Shopify Admin, as well as experiencing issues with storefronts and checkouts. We’re investigating the issue and will keep you updated.”

Noted Twitter user William Shatner was less reserved: “Shopify is down! My store is unreachable! I’m losing million(s) of dollars every minute in potential sales!” Not great public relations for a company whose stock had already tanked 10% that week.

It may be time to start taking overvalued names off the table, with Netflix also taking a beating last week, compounding U.S. tech woes. Meanwhile, tech investors seeking new opportunities will soon have a hot IPO to check out. Apple device management provider Jamf is expected to go public July 23 offering fresh momentum at the ground level.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. David Gardner owns shares of Apple and Netflix. Tom Gardner owns shares of Netflix, Shopify, and Twitter. The Motley Fool owns shares of and recommends Apple, Netflix, Shopify, Shopify, and Twitter. The Motley Fool recommends KINAXIS INC.

More on Tech Stocks

Wireless technology
Tech Stocks

2 Quality Growth Stocks Breathe Life Into the Tech Sector

The battered technology sector has been advancing lately thanks to two quality growth stocks with pricing powers.

Read more »

clock time
Tech Stocks

Now’s the Time to Load Up the TFSA With These 2 Top TSX Stocks

Here are two top TSX stocks that long-term growth investors may not want to give up on, especially at these…

Read more »

shopping online, e-commerce
Tech Stocks

Shopify (TSX:SHOP) Stock Recovers 30% From its 3-Year Lows: Should You Buy?

Shopify stock: Should you buy the dip or wait for more weakness?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Tech Stocks

What Market Correction? 2 High-Growth Tech Stocks That Are on the Rise

I don’t think it will be long before these two Canadian tech stocks are back to delivering market-crushing returns.

Read more »

grow dividends
Tech Stocks

Why Kinaxis (TSX:KXS) Stock Jumped 14% Last Week

Kinaxis Inc. (TSX:KXS) stock popped over the past week after adding yet another big company to its impressive stable.

Read more »

potted green plant grows up in arrow shape
Tech Stocks

TFSA Investors: Double Your Investments With These 3 Top Growth Stocks

Despite the volatility, I am bullish on these three stocks, given their solid growth potential.

Read more »

Arrow descending on a graph
Tech Stocks

2 Industries That Saw the Worst Decline Last Month

The TSX has been declining at a sharp angle since the beginning of June. And two industries (crypto and cannabis)…

Read more »

Dividend Stocks

TFSA Investors: Turn $1,000 Into $10,000 in 10 Years

10-fold growth within a decade is rare but not unheard of. You can capture this growth either by predicting a…

Read more »